GlassScriptPhysician profile
Anna Nguyen
NPI 1003406406
$1,326.74
in general payments reported to CMS, 2019-2025
9 companies · $150 in 2025
The $150 reported for 2025 was less than what a typical Medical provider received nationally (typical 2025 total: $213).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $228 · 2022: $710 · 2023: $42.92 · 2024: $196 · 2025: $150.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $389.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $388.65 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $574.55 | 2021-2025 | |
| Boston Scientific Corporation | $187.66 | 2022-2024 | Vercise |
| Galderma Laboratories, L.P. | $146.13 | 2024 | Dysport |
| Genzyme Corporation | $122.67 | 2021 | |
| Biohaven Pharmaceutical Holding Company LTD. | $100.83 | 2022 | |
| Allergan, INC. | $100.60 | 2021-2022 | |
| Nevro Corp. | $58.62 | 2022 | |
| Biohaven Pharmaceuticals, INC. | $21.29 | 2021 | |
| Array Biopharma INC | $14.39 | 2023 | Mektovi, Braftovi |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Anna Nguyen listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.